Dihydrocodeine is a semi-synthetic opioid analgesic, typically used for the management of moderate to severe pain related instances, severe dyspnea, and also as an antitussive. Developed in Germany in 1908, Dihydrocodeine was first launched into the commercial market in 1911 and remains in common usage today. It is often combined with other analgesics like paracetamol or aspirin to increase its pain-relieving efficiency. Furthermore, it functions by interacting with the opioid receptors in the brain and spinal cord, aiding in the reduction of the overall sentiment of pain.
![5-methoxy-3a1-(2-methoxyethyl)-9-(methylamino)-1,2,3,3a,3a1,8,9,9a-octahydrophenanthro[4,5-bcd]furan-3-ol](https://veeprho.com/wp-content/uploads/2025/02/VE0023110-5-methoxy-3a1-2-methoxyethyl.png "5-methoxy-3a1-(2-methoxyethyl)-9-(methylamino)-1,2,3,3a,3a1,8,9,9a-octahydrophenanthro[4,5-bcd]furan-3-ol")
Parent: Dihydrocodeine
![5,9-dimethoxy-3a1-(2-(methylamino)ethyl)-1,2,3,3a,3a1,8,9,9a-octahydrophenanthro[4,5-bcd]furan-3-ol](https://veeprho.com/wp-content/uploads/2025/02/VE0023109-5-9-dimethoxy-3a1-2-methylamino.png "5,9-dimethoxy-3a1-(2-(methylamino)ethyl)-1,2,3,3a,3a1,8,9,9a-octahydrophenanthro[4,5-bcd]furan-3-ol")
Parent: Dihydrocodeine
The Dihydrocodeine molecule can be susceptible to the generation of impurities and related substances due to various factors such as manufacturing processes, degradation, storage conditions, and others. Impurities associated with Dihydrocodeine might include Dihydrothebaine, Codeine, and other potential semi-synthetic opioids. However, the quantity of these impurities is regulated by acceptable pharmaceutical standards to ensure product safety. Analytical methods such as high-performance liquid chromatography are commonly used to detect these levels, with concentrations generally maintained within an acceptable parts-per-million range.
Yes, Dihydrocodeine is considered a strong painkiller. It’s an opioid analgesic, which means it’s designed for the relief of moderate to severe pain. However, its potency could vary based on dosage and the individual’s tolerance to opioids.
No, Dihydrocodeine is not a form of morphine but they both belong to the same category of drugs called opioids. They function in a similar way by influencing the opioid receptors in the brain to reduce the sensation of pain.
The recommended dosage of Dihydrocodeine varies depending on a person’s age, health state and the specific pain condition being treated. It’s crucial that patients strictly follow the prescribed dosage from their healthcare professional.
In the US, Dihydrocodeine is marketed under various trade names such as Parzone, DHC Continus and more. However, it’s always important to verify the contents of the medication before usage.
